We just learned that Dr. Brown passed away at his home Sunday night, Dec. 1. We are reposting this recent story in his honor. He will be missed.
Advocates for Arthritis Will Target Step Therapy, Workforce Shortage
The 2019 event, to be held Sept. 9-10 in Washington, D.C., will bring together rheumatology professionals and patients to advocate on behalf of the rheumatology community.
Proposed 2020 E/M Codes Include Reimbursement Changes
Increased reimbursement would reflect value of cognitive care and other time-intensive services provided by rheumatologists.
CMS 2020 Quality Payment Program Proposed Rule Contains Key Changes to MIPS Reporting
The CMS 2020 Proposed Rule for the Quality Payment Program, released July 29, contains several key changes relevant to MIPS-eligible clinicians.
ARP Pre-Meeting Course Explores the Role of Precision Medicine
Precision medicine is a hot topic, but what does it mean for clinical practice in rheumatology? This year’s Annual Meeting ARP Pre-Meeting Course will explore precision medicine’s implications for biomarkers, pharmacogenomics, psychosocial aspects of care and more…
Why Are Frogs’ Tongues So Sticky? Insights into Locomotion & Healthcare at the 2019 Annual Meeting
During this year’s ACR/ARP Annual Meeting Opening Lecture, David Hu, PhD, will discuss the blend of engineering and biology through his quirky, illuminating research on locomotion…
What’s In the Rheum? The ACR/ARP Annual Meeting’s Latest Engaging Session Format
Designed in the TED Talk style, In the Rheum sessions will feature the hottest topics and biggest scientific takeaways for rheumatology using a shorter, more casual approach during the 2019 ACR/ARP Annual Meeting…
Multiple Interferons, Including IFNB1, May Play a Role in SLE
A recent gene expression analysis found an enriched downstream interferon signature, with predominantly IFNB1 signatures in systemic lupus erythematosus (SLE) patients. The study also found lower expression of all downstream interferon signatures in the kidneys of lupus nephritis patients…
Amgen Wins U.S. Patent Battle on Arthritis Drug Enbrel
(Reuters)—A U.S. judge on Friday upheld two patents relating to Amgen Inc,’s blockbuster rheumatoid arthritis drug Enbrel (etanercept), denying a challenge by Novartis AG, which is seeking to launch a biosimilar version. The decision was a relief to investors concerned about a competitive threat to Enbrel, which had U.S. sales of $4.8 billion last year….
Professional Coaching Can Contribute to Physician Well-Being
NEW YORK (Reuters Health)—Professional coaching can improve the well-being and reduce the distress of physicians, researchers have found. “With over 40% of physicians having substantial symptoms of burnout, professional coaching is one strategy that should be offered to help them recover,” Liselotte N. Dyrbye, MD, MHPE, from Mayo Clinic, Rochester, Mn., tells Reuters Health by…
- « Previous Page
- 1
- …
- 232
- 233
- 234
- 235
- 236
- …
- 799
- Next Page »